BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Respira Therapeutics Announces Late-breaking Presentation of RT234 Phase 2b PAH Clinical Trial Results at the American Thoracic Society (ATS) 2025 International Conference

  May 19, 2025

   · 

  1 min read
• Press Releases

  CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA® (pembrolizumab) in Patients with Metastatic Melanoma

  May 19, 2025

   · 

  6 min read
• Press Releases

  Izotropic’s U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update

  May 19, 2025

   · 

  5 min read
• Press Releases

  High SCA Treatment Rates Despite Contemporary GDMT in 19,000+ Consecutive LifeVest® Patient Study

  May 19, 2025

   · 

  6 min read
• Press Releases

  Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors

  May 19, 2025

   · 

  5 min read
• Press Releases

  SynOligo Biotechnologies and Lumiphore Announce a Partnership to Provide [Time-Resolved] Luminescent Oligos and Assays for the Nucleic Acid Amplification Testing Market (NAAT)

  May 19, 2025

   · 

  1 min read
• Press Releases

  BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference

  May 19, 2025

   · 

  5 min read
• Press Releases

  SNS812, an innovative siRNA drug from Oneness and Microbio (Shanghai), selected for ATS 2025 oral presentation, demonstrating world-leading clinical outcomes in COVID-19 treatment

  May 19, 2025

   · 

  3 min read
• Press Releases

  2025 EASL Congress Spotlight: CG-0416 Preclinical Data Unveils A Groundbreaking Dual-Action Therapy Targeting Obesity and MASH

  May 19, 2025

   · 

  5 min read
• Press Releases

  WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA

  May 19, 2025

   · 

  9 min read